These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10360861)

  • 21. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery.
    Grassin-Delyle S; Couturier R; Abe E; Alvarez JC; Devillier P; Urien S
    Anesthesiology; 2013 Apr; 118(4):853-62. PubMed ID: 23343649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety.
    Sarupria A; Makhija N; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):23-9. PubMed ID: 22995453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery.
    Breda JR; Gurian DB; Breda AS; Meneghine A; Freitas AC; Matos LL; Abreu LC; Pires AC
    Rev Bras Cir Cardiovasc; 2009; 24(3):341-5. PubMed ID: 20011881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. The Multicenter Study of Perioperative Ischemia Research Group.
    Bailey JM; Mora CT; Shafer SL
    Anesthesiology; 1996 Jun; 84(6):1288-97. PubMed ID: 8669668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHARMACOKINETIC STUDY OF ORAL ε-AMINOCAPROIC ACID IN THE NORTHERN ELEPHANT SEAL (MIROUNGA ANGUSTIROSTRIS).
    Kaye S; Johnson S; Arnold RD; Nie B; Davis JT; Gulland F; Abou-Madi N; Fletcher DJ
    J Zoo Wildl Med; 2016 Jun; 47(2):438-46. PubMed ID: 27468014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects.
    Frederiksen MC; Bowsher DJ; Ruo TI; Henthorn TK; Ts'ao CH; Green D; Atkinson AJ
    Clin Pharmacol Ther; 1984 Mar; 35(3):387-93. PubMed ID: 6697646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-administration of aprotinin and epsilon-aminocaproic acid during cardiopulmonary bypass in a swine model.
    Vang SN; Stammers AH; Mejak BL; Rauch ED; Viessman TW; Bruda NL; Yang T
    J Extra Corpor Technol; 2000 Dec; 32(4):196-206. PubMed ID: 11194056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
    Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome.
    Martin K; Gertler R; MacGuill M; Mayr NP; Hapfelmeier A; Hörer J; Vogt M; Tassani P; Wiesner G
    Br J Anaesth; 2013 Apr; 110(4):615-21. PubMed ID: 23213034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unexpected higher blood loss associated with higher dose ε-aminocaproic acid in pediatric scoliosis surgery.
    Lam H; Austin T; Nguyen T; Martus J; Schoenecker J
    J Pediatr Orthop B; 2019 Jan; 28(1):40-44. PubMed ID: 30199414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic plasma concentrations of epsilon aminocaproic acid and tranexamic acid in horses.
    Fletcher DJ; Brainard BM; Epstein K; Radcliffe R; Divers T
    J Vet Intern Med; 2013; 27(6):1589-95. PubMed ID: 24118238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of tranexamic acid in neonates and infants undergoing cardiac surgery.
    Gertler R; Gruber M; Grassin-Delyle S; Urien S; Martin K; Tassani-Prell P; Braun S; Burg S; Wiesner G
    Br J Clin Pharmacol; 2017 Aug; 83(8):1745-1757. PubMed ID: 28245519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment.
    Yang QJ; Jerath A; Bies RR; Wąsowicz M; Pang KS
    Biopharm Drug Dispos; 2015 Jul; 36(5):294-307. PubMed ID: 25704361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee Arthroplasty.
    Churchill JL; Puca KE; Meyer E; Carleton M; Anderson MJ
    J Knee Surg; 2017 Jun; 30(5):460-466. PubMed ID: 27699724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
    Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
    J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cardiopulmonary bypass on sufentanil pharmacokinetics in patients undergoing coronary artery bypass surgery.
    Hudson RJ; Thomson IR; Jassal R
    Anesthesiology; 2004 Oct; 101(4):862-71. PubMed ID: 15448518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid.
    Maineri P; Covaia G; Realini M; Caccia G; Ucussich E; Luraschi M; Crosta A; Foresti B; Chiaranda M
    Minerva Cardioangiol; 2000 Jun; 48(6):155-60. PubMed ID: 11048468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report.
    Prandota J; Pankow-Prandota L; Kotecki L; Noga L
    Am J Ther; 2001; 8(2):97-107. PubMed ID: 11304663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.